A Walgreens keep is viewed in Chicago, Illinois, U.S. February 11, 2021. REUTERS/Eileen T. Meslar
Oct 14 (Reuters) - Walgreens Boots Alliance Inc's (WBA.O) fourth-quarter outcomes beat estimates on greater U.S. and UK pharmacy store income due to the easing of pandemic-connected restrictions and individuals getting COVID-19 vaccines at its shops.
The company has administered greater than 40 million COVID-19 vaccines and over 16 million exams to date, it stated.
identical-store revenue at its U.S. pharmacies rose eight.eight% in the fourth quarter, which covered a 485 foundation aspect boost from COVID-19 vaccinations, the enterprise mentioned. Walgreens filled 313 million prescriptions all the way through the quarter.
Shares within the Deerfield, Illinois-primarily based business, one of the vital greatest U.S. pharmacies, rose 1.6% to $48 premarket.
net profits because of the business bec ome $627 million, or 72 cents per share, for the quarter ended Aug. 31, compared with a earnings of $373 million, or forty three cents per share, a yr previous.
with the exception of objects, the company earned $1.17 per share, in comparison with Refinitiv IBES estimates of $1.02 per share.
earnings rose to $34.26 billion from $30.37 billion, whereas analysts on standard had estimated $33.30 billion.
Reporting by way of Dania Nadeem and Leroy Leo in Bengaluru; enhancing with the aid of Vinay Dwivedi
Our standards: The Thomson Reuters trust concepts.
0 Comments